| Hazard Information | Back Directory | [Uses]
HDAC-IN-74 (PA) is a dual HDAC/Rribonucleotide reductase(RR) inhibitor, with IC50 values ??of 10.80 μM and 9.34 μM for HDAC and HDAC, respectively. HDAC-IN-74 can be used in anticancer research[1]. | [IC 50]
HDAC: 10.8 μM (IC50) | [References]
[1] Shetty MG,et al. Evaluation of 1,10-phenanthroline-based hydroxamate derivative as dual histone deacetylases/ribonucleotide reductase inhibitor with antitumor activities. Daru. 2024 Jun;32(1):263-278. DOI:10.1007/s40199-024-00514-1 |
|
|